Related Experiment Videos
[Epidemiology of purpura fulminans and early therapeutic recommendations]
1Service de pédiatrie, centre hospitalier intercommunal de Créteil, 40 avenue de Verdun, 94010 Créteil, France. reinert@club-internet.fr
Insights
Meningococcemia causes significant mortality in France. Prompt parenteral antibiotic administration, especially ceftriaxone or cefotaxime, substantially reduces death rates in suspected purpura fulminans cases.
Area of Science:
- Pediatrics
- Infectious Diseases
- Public Health
Background:
- Meningococcemia is a significant cause of mortality in pediatric intensive care in France, with rates between 10% and 30%.
- Immediate parenteral antibiotic administration is crucial for reducing mortality associated with meningococcemia.
Purpose of the Study:
- To outline recommendations for the prompt management of suspected purpura fulminans.
- To emphasize the importance of early antibiotic intervention in reducing meningococcemia-related deaths.
Main Methods:
- Review of current mortality data for meningococcemia in France.
- Analysis of the impact of parenteral antibiotic timing on mortality outcomes.
- Incorporation of recommendations from the Conseil supérieur d'hygiène publique de France.
Main Results:
- Parenteral antibiotics significantly reduce meningococcemia mortality.
- Specific antibiotics like ceftriaxone, cefotaxime, and amoxicillin are recommended.
Conclusions:
- General practitioners should administer antibiotics promptly, preferably intravenously, upon suspicion of purpura fulminans.
- Timely administration of recommended antibiotics (ceftriaxone, cefotaxime, amoxicillin) is vital for improving patient outcomes and reducing mortality in meningococcemia.
Abstract:
Despite major advances in pediatrics intensive care, meningococcemia remains an important cause of mortality en France (10 to 30%). Parenteral antibiotic given immediately is associated with a substantial reduction in mortality. So the Conseil supérieur d'hygiène publique de France recommend that general practitioners should administer promptly, preferably intravenously, whenever purpura fulminans is suspected, ceftriaxone (i.m., i.v.), cefotaxime (i.v.) or Amoxicillin (i.m., i.v.).
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Myocarditis III: Medical Management
Acute Pyelonephritis II: Diagnostic Studies and Management
Venous Thrombosis IV: Nursing Management
Pulmonary Embolism III: Nursing Management